Waterval, N. F. J.
van der Krogt, M. M.
Veerkamp, K.
Geijtenbeek, T.
Harlaar, J.
Nollet, F.
Brehm, M. A.
Funding for this research was provided by:
ZonMw (104022003)
Article History
Received: 9 August 2022
Accepted: 24 August 2023
First Online: 7 September 2023
Declarations
:
: All participants provided written informed consent before inclusion. The study protocol of the PROOF-AFO trial was approved by the medical ethics committee of the Academic Medical Center (AMC) in Amsterdam, The Netherlands (register: METC_2014_397).
: Not applicable.
: The authors declare that they have no competing interest.